Document is current
Any future updates will be listed below
-
Authors
Balitsky, Amaris http://orcid.org/0000-0002-2831-9107
Pond, GR
Davies, GA
Fraser, G
Kouroukis, T
Levine, M
Meyer, RM
Foley, R
- License Information
-
More Information
Article History
Received: 21 August 2023
Accepted: 27 June 2024
First Online: 9 August 2024
Declarations
:
: The protocol was reviewed by Hamilton Integrated Research Ethics Board (HIREB) and all patients signed an informed consent form.
: Not applicable.
: AB, honoraria from Novartis, BMS and Kite/Gilead; GP, honorarium from Takeda, consulting fees from Merck, Astra-Zeneca and Profound Medical, close family member who is an employee of Roche Canada and owns stock in Roche Ltd; GF none; GD Honoraria from Janssen and Roche; TK none; ML none; MR none; RF honoraria from Janssen, Novartis, BMS, Gilead, and consultancy from Novartis, Gilead.
